A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
for Major Depressive Disorder
31 locations incl. Phoenix
Sponsor: Syndeio Biosciences, Inc
Sex: All·Age: 18 - 64
Code: NCT07115329·Phase 2·Recruiting·Listed Aug 2025